Start an analysis for NUS
NuSkin Enterprises, Inc.
Stock · NYSEProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $500m | 30-Sep-26 | 10-Q filed 05-Nov-26 |
| Remaining authorization | $137m | 30-Sep-26 | 10-Q filed 05-Nov-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | $0 | 30-Sep-26 | 10-Q filed 05-Nov-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| Not found in filings | $500m | $137m | n/a | In August 2018, we announced that our board of directors approved a stock repurchase plan. Under this plan, our board of directors authorized the repurchase of up to $500 million of our outstanding Class A common stock on the open market or in privately negotiated transactions.10-Q filed 05-Nov-26 |
Open-market repurchases
- Apr ’26
- May ’26
- Jun ’26
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|
| 30-Sep-26 | 0 | — | $0 | 10-Q filed 05-Nov-26 |
| 31-Aug-26 | 0 | — | $0 | 10-Q filed 05-Nov-26 |
| 31-Jul-26 | 0 | — | $0 | 10-Q filed 05-Nov-26 |
| 30-Jun-26 | 0 | — | $0 | 10-Q filed 10-Aug-26 |